您的位置:首页  > 论文页面

中医学与中药学癌性贫血的中西医研究现状及前景展望

发表时间:2009-12-15  浏览量:1628  下载量:808
全部作者: 荣秀梅,李冬云
作者单位: 北京中医药大学东直门医院血液肿瘤科
摘 要: 癌性贫血临床治疗的主要方法是重组人类促红细胞生成素(recombinant human erythropoietin,rHuEPO)治疗、输血治疗及中医药治疗。研究表明:促红细胞生成素(erythropoietin,EPO)可以改善甚至纠正贫血,是目前较为公认的治疗癌性贫血的方法,但亦有学者对其疗效及安全问题存在疑虑,其具体应用有待进一步考究。输血治疗改善贫血速度快,但维持时间较短。传统中医药治疗贫血临床研究有确切疗效,但其药物机制尚未完全明了。从中西医结合的角度分析癌性贫血的发生及治疗,旨在研究有效、安全、经济的治疗方法和手段,以延长肿瘤患者的生存时间,并提高其生活质量。
关 键 词: 肿瘤学;贫血;综述;中西医;治疗
Title: The study and outlook of both Chinese and western medicine on cancer-related anemia
Author: RONG Xiumei, LI Dongyun
Organization: Department of Hematology-oncology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Abstract: Therapeutic interventions on cancer-related anemia in clinic mainly include blood transfusions, administration of recombinant human erythropoietin (rHuEPO) and herbs. Studies show that, erythropoietin (EPO) is the best therapeutic tool up to now, and it can improve the HGB effectively, however, there are some experts hold different ideas about the safety and effect, which needs to be further discussed. Blood transfusion can remedy anemia soon, however, it can not sustain long. Traditional herbs have been demonstrated in effect in clinic studies, but its extensional mechanism is not clear. The occurrence and treatment of cancer-related anemia are shown from the views of integrated traditional and western medicine in this paper. And safe, effective and economical methods are expected to be discovered, so the patients' life can be prolonged and quality of life can be improved.
Key words: oncology; anemia; review; Chinese and western medicine; treatment
发表期数: 2009年12月第23期
引用格式: 荣秀梅,李冬云. 中医学与中药学癌性贫血的中西医研究现状及前景展望[J]. 中国科技论文在线精品论文,2009,2(23):2480-2488.
 
0 评论数 0
暂无评论
友情链接